Here you can find a continually updated listing of Memorial Sloan-Kettering’s current clinical trials for thyroid cancer. To learn more about a study, choose from the list below.
| Title | Investigator |
|---|---|
|
A Phase I Study of PLX3397 in Patients with Advanced Solid Tumors [Protocol 12-156] |
Tap, William, MD |
|
A Phase II Study of Concurrent Intensity-Modulated Radiation Therapy (IMRT),
Paclitaxel, and Pazopanib/Placebo for the Treatment of Anaplastic Thyroid Cancer [Protocol 10-186] |
Sherman, Eric, MD |
|
A Phase II Study of Sorafenib in Children and Young Adults with Relapsed/Refractory Rhabdomyosarcoma, Wilms Tumor, Hepatocellular Carcinoma, or Papillary Thyroid Cancer [Protocol 12-139] |
Trippett, Tanya, MD |
Related Topics
Recommended Links
